secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2023-04-18T23:59:59+00:00
Accession:  0001104659-23-046698
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio preliminary Q1 revenue $11.9M, up 45% YoY; cash $30.1M
---------------------------------------------------------------

- Revenue estimated at $11.9M for Q1 2023 vs $8.2M in Q1 2022, a 45% increase.
- Cash and equivalents $30.1M at March 31, 2023, down from $42.0M at Dec 31, 2022.
- Results are preliminary and subject to change upon completion of quarter-end closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923046698/0001104659-23-046698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923046698/tm232660d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-046698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer